Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Application Segment
1.1.2. Product & Service Segment
1.1.3. Workflow Segment
1.1.4. End Use Segment
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Primary Research
1.5. Information or Data Analysis:
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objective
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables & Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological advancements in exosomes isolation and analytical procedures
3.2.1.2. Advanced applications of exosomes
3.2.1.3. Growth in strategic initiatives for exosome-based therapies
3.2.1.4. Increasing prevalence of cancer
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulations pertaining to approval
3.2.2.2. Challenges associated with the implementation of exosome-based therapies
3.2.2.3. Reduction in funding for biomedical research
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. U.S. Exosomes Market Product & Service Estimates & Trend Analysis
4.1. U.S. Exosomes Product & Service Dashboard
4.2. U.S. Exosomes Product & Service Movement Analysis
4.3. Kits & Reagents
4.3.1. Kits & Reagents Market, 2021-2033 (USD Million)
4.4. Instruments
4.4.1. Instruments Market, 2021-2033 (USD Million)
4.5. Services
4.5.1. Services Market, 2021-2033 (USD Million)
Chapter 5. U.S. Exosomes Market Application & Trend Analysis
5.1. U.S. Exosomes Market Application Dashboard
5.2. U.S. Exosomes Market Application Movement Analysis
5.3. Cancer
5.3.1. Cancer Market, 2021-2033 (USD Million)
5.4. Neurodegenerative Diseases
5.4.1. Neurodegenerative Diseases Market, 2021-2033 (USD Million)
5.5. Cardiovascular Diseases
5.5.1. Cardiovascular Diseases Market, 2021-2033 (USD Million)
5.6. Infectious Diseases
5.6.1. Infectious Diseases Market, 2021-2033 (USD Million)
5.7. Others
5.7.1. Other Applications Market, 2021-2033 (USD Million)
Chapter 6. U.S. Exosomes Market Workflow Estimates & Trend Analysis
6.1. U.S. Exosomes Market Workflow Dashboard
6.2. U.S. Exosomes Market Workflow Movement Analysis
6.3. Isolation Methods
6.3.1. Isolation Methods Market, 2021-2033 (USD Million)
6.3.2. Ultracentrifugation
6.3.2.1. Ultracentrifugation Market, 2021-2033 (USD Million)
6.3.3. Immunocapture On Beads
6.3.3.1. Immunocapture On Beads Market, 2021-2033 (USD Million)
6.3.4. Precipitation
6.3.4.1. Precipitation Market, 2021-2033 (USD Million)
6.3.5. Filtration
6.3.5.1. Filtration Market, 2021-2033 (USD Million)
6.3.6. Others
6.3.6.1. Other Isolation Methods Market, 2021-2033 (USD Million)
6.4. Downstream Analysis
6.4.1. Downstream Analysis Market, 2021-2033 (USD Million)
6.4.2. Cell Surface Marker Analysis Using Flow Cytometry
6.4.2.1. Cell Surface Marker Analysis Using Flow Cytometry Market, 2021-2033 (USD Million)
6.4.3. Protein Analysis Using Blotting & ELISA
6.4.3.1. Protein Analysis Using Blotting & ELISA Market, 2021-2033 (USD Million)
6.4.4. RNA Analysis With NGS & PCR
6.4.4.1. RNA Analysis With NGS & PCR Market, 2021-2033 (USD Million)
6.4.5. Proteomic Analysis Using Mass Spectrometry
6.4.5.1. Proteomic Analysis Using Mass Spectrometry Market, 2021-2033 (USD Million)
6.4.6. Others
6.4.6.1. Other Downstream Analysis Market, 2021-2033 (USD Million)
Chapter 7. U.S. Exosomes Market End Use Estimates & Trend Analysis
7.1. U.S. Exosomes Market End Use Dashboard
7.2. U.S. Exosomes Market End Use Movement Analysis
7.3. Pharmaceutical & Biotechnology Companies
7.3.1. Pharmaceutical & Biotechnology Companies Market, 2021-2033 (USD Million)
7.4. Hospitals & Diagnostics Centers
7.4.1. Hospitals & Diagnostics Centers Market, 2021-2033 (USD Million)
7.5. Academic & Research Institutes
7.5.1. Academic & Research Institutes Market, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Company Market Position Analysis, 2025
8.3. Company Profiles
8.3.1. Danaher
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Thermo Fisher Scientific, Inc.
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Hologic Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Bio-Techne
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. RoosterBio, Inc
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Fujifilm Holdings Corporation
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Lonza
8.3.7.1. Company Overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Miltenyi Biotec
8.3.8.1. Company Overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. QIAGEN
8.3.9.1. Company Overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. CellBio Scientific
8.3.10.1. Company Overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
List of Tables
Table 1. List of abbreviations
Table 2. U.S. Exosomes Market, By Product, 2021-2033 (USD Million)
Table 3. U.S. Exosomes Market, By Application, 2021-2033 (USD Million)
Table 4. U.S. Exosomes Market, By Workflow, 2021-2033 (USD Million)
Table 5. U.S. Exosomes Market, By End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 U.S. Exosomes Market Segmentation
Figure 8 Market Driver Relevance Analysis (Current & Future Impact)
Figure 9 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 10 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Figure 11 Porter’s Five Forces Analysis
Figure 12 U.S. Exosomes Market: Product & service outlook and key takeaways
Figure 13 U.S. Exosomes Market: Product & service movement analysis & market share 2025 & 2033
Figure 14 Kits & reagents market, 2021-2033 (USD Million)
Figure 15 Instruments market, 2021-2033 (USD Million)
Figure 16 Services market, 2021-2033 (USD Million)
Figure 17 U.S. Exosomes Market: Application outlook and key takeaways
Figure 18 U.S. Exosomes Market: Application movement analysis & market share
Figure 19 Isolation methods market, 2021-2033 (USD Million)
Figure 20 Ultracentrifugation market, 2021-2033 (USD Million)
Figure 21 Immunocapture on beads market, 2021-2033 (USD Million)
Figure 22 Precipitation market, 2021-2033 (USD Million)
Figure 23 Filtration market, 2021-2033 (USD Million)
Figure 24 Other isolation methods market, 2021-2033 (USD Million)
Figure 25 Downstream analysis market, 2021-2033 (USD Million)
Figure 26 Cell surface marker analysis using flow cytometry market, 2021-2033 (USD Million)
Figure 27 Protein analysis using blotting & ELISA market, 2021-2033 (USD Million)
Figure 28 RNA analysis with NGS & PCR market, 2021-2033 (USD Million)
Figure 29 Proteomic analysis using mass spectroscopy market, 2021-2033 (USD Million)
Figure 30 Other downstream analysis market, 2021-2033 (USD Million)
Figure 31 U.S. Exosomes Market: Application outlook and key takeaways
Figure 32 U.S. Exosomes Market: Application movement analysis & market share
Figure 33 Cancer market, 2021-2033 (USD Million)
Figure 34 Neurodegenerative diseases market, 2021-2033 (USD Million)
Figure 35 Cardiovascular diseases market, 2021-2033 (USD Million)
Figure 36 Infectious diseases market, 2021-2033 (USD Million)
Figure 37 Other applications market, 2021-2033 (USD Million)
Figure 38 U.S. Exosomes Market: End use outlook and key takeaways
Figure 39 U.S. Exosomes Market: End use movement analysis & market share
Figure 40 Pharmaceutical & biotechnology companies market, 2021-2033 (USD Million)
Figure 41 Hospitals & diagnostics centers market estimates and forecast, 2021-2033
Figure 42 Academic and research institutes market estimates and forecast, 2021-2033
Figure 43 Others market estimates and forecasts, 2021-2033
